Johnson & Johnson JNJ, +1.05% stock rose nearly 3% in the extended session Tuesday after the company said that its subsidiary LTL Management LLC has re-filed for voluntary Chapter 11 bankruptcy protec

Merck (MRK), Seagen Drug Combo Gets FDA Nod for Bladder Cancer

02:17pm, Tuesday, 04'th Apr 2023 Zacks Investment Research
The combination of Merck's (MRK) Keytruda and Seagen's (SGEN) Padcev is the first approved immunotherapy and an antibody-drug conjugate for locally advanced or metastatic urothelial carcinoma.

3 Top Healthcare Stocks to Buy for April

01:12pm, Tuesday, 04'th Apr 2023 The Motley Fool
These pharmaceutical companies' shares are down, but their prospects are rising.

3 Dividend Aristocrats That Generate Income For Life

11:00am, Tuesday, 04'th Apr 2023 Seeking Alpha
When I retire, I plan to live off an income portfolio of at least $1 million. Find out 3 of my favorite dividend aristocrats that are part of my portfolio.

3 Top Healthcare Stocks to Buy for April

09:12am, Tuesday, 04'th Apr 2023
Eli Lilly's promising diabetes drug Mounjaro could be an obesity-therapy blockbuster. Johnson & Johnson's consumer healthcare spinoff will make the company more profitable.
JNJ is a dividend king for having increased their dividend for 50+ consecutive years. At the end of the year, JNJ will be spinning off its consumer health segment into a separate public company called

3 Dow Stocks That Are Screaming Buys in April

09:06am, Tuesday, 04'th Apr 2023 The Motley Fool
Among the Dow Jones Industrial Average's 30 components, there are three plain-as-day bargains.

9 Upcoming Dividend Increases In April 2023

06:00am, Tuesday, 04'th Apr 2023 Seeking Alpha
Dividends are the foundation of our goal to reach financial freedom. We continuously invest in dividend growth stocks to grow our passive income.

9 Upcoming Dividend Increases In April 2023

02:00am, Tuesday, 04'th Apr 2023
Dividends are the foundation of our goal to reach financial freedom. We continuously invest in dividend growth stocks to grow our passive income.

AstraZeneca (AZN) Ultomiris Gets CHMP Nod for New Rare Disease

04:09pm, Monday, 03'rd Apr 2023 Zacks Investment Research
CHMP recommends AstraZeneca's (AZN) Ultomiris for the treatment of patients with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 antibody positive.

Novartis (NVS) Gets CHMP Positive Opinion for Entresto Approval

03:55pm, Monday, 03'rd Apr 2023 Zacks Investment Research
Novartis (NVS) receives a positive opinion from the CHMP for Entresto (sacubitril/valsartan) for a new indication in pediatric patients.
These blue chips are down. Is it time to buy?

3 Dow Stocks With Above-Average Dividends Yields to Buy in April

09:39am, Monday, 03'rd Apr 2023 The Motley Fool
Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now.

3 Top S&P 500 Stocks Near 52-Week Lows That Look Like Bargains Now

09:27am, Monday, 03'rd Apr 2023 The Motley Fool
Now's a great time to buy some shares of these highly reliable dividend-payers.
Honeywell is coming off a strong fourth quarter, but sees moderating growth in 2023. Johnson & Johnson is dealing with costly litigation over its baby powder.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE